MedTrace Logo

EMD for Treatment of Proximal Class-II Furcation Involvements

NCT03320135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2019-06-05

No results posted yet for this study

Summary

The aim of the present study is to evaluate the clinical response of proximal furcations treated with enamel matrix derivative proteins (EMD).

Conditions

  • Generalized Aggressive Periodontitis

Interventions

PROCEDURE

Enamel matrix derivative proteins

Open flap debridement to enamel matrix derivative to treat proximal furcation involvements.

PROCEDURE

Open Flap debridement

Open flap debridement will be performed to decontaminate the proximal furcation involvements.

Sponsors & Collaborators

  • Universidade Estadual Paulista Júlio de Mesquita Filho

    lead OTHER

Principal Investigators

  • Mauro M Santamaria, DDS, PhD · Universidade Estadual Paulista "Julio de Mesquita Filho", ICT/UNESP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2018-10-20
Completion
2019-05-20

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320135 on ClinicalTrials.gov